The most frequently encountered answer was responsiveness to conservative/calcimimetics treatment (n = 16), results of screening for other causes of hypercalcemia (n = 6), PTH stability (n = 5), eligibility of patient for kidney donation (n = 5) and the presence of complications due to hypercalcemia (n = 5). This evidence concerns the gene PTH and hypercalcemia disease.